A detailed history of Yarbrough Capital, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Yarbrough Capital, LLC holds 5,276 shares of CTLT stock, worth $309,859. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,276
Previous 5,276 -0.0%
Holding current value
$309,859
Previous $296,000 7.77%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 13, 2023

BUY
$45.44 - $74.26 $239,741 - $391,795
5,276 New
5,276 $346,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Yarbrough Capital, LLC Portfolio

Follow Yarbrough Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yarbrough Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yarbrough Capital, LLC with notifications on news.